Ximelagatran (Exanta or Exarta, H 376/95) is an anticoagulant that has been investigated extensively as a replacement for warfarin that would overcome...
11 KB (972 words) - 19:24, 20 December 2023
approved by the FDA. Some of them (lumiracoxib, rimonabant, tolrestat, ximelagatran and ximelidine, for example) were approved to be marketed in Europe but...
45 KB (1,903 words) - 22:46, 13 August 2024
drugs argatroban and dabigatran. An oral direct thrombin inhibitor, ximelagatran (Exanta), was denied approval by the Food and Drug Administration (FDA)...
78 KB (8,755 words) - 00:46, 23 July 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
56 KB (5,566 words) - 02:21, 16 August 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
79 KB (6,533 words) - 11:42, 20 June 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
10 KB (740 words) - 16:13, 20 July 2024
Maximum sizes of ecological populations Side effects of drugs (e.g., ximelagatran) The magnitudes of large insurance losses Equity risks; day-to-day market...
28 KB (2,729 words) - 08:26, 18 August 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
87 KB (8,744 words) - 18:03, 16 August 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
42 KB (3,794 words) - 22:28, 15 August 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
31 KB (2,605 words) - 23:47, 9 July 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
41 KB (3,439 words) - 18:35, 12 August 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
31 KB (2,739 words) - 18:31, 9 August 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
14 KB (1,360 words) - 16:20, 23 June 2024
Univalent DTIs include: Argatroban Inogatran Melagatran (and its prodrug ximelagatran) Dabigatran Thrombin demonstrates a high level of allosteric regulation...
7 KB (821 words) - 09:44, 30 January 2023
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
16 KB (1,231 words) - 04:59, 4 February 2024
double prodrug which was the first oral DTI in clinical trials, ximelagatran. Ximelagatran was on the European market for approximately 20 months when it...
33 KB (3,756 words) - 17:07, 14 December 2023
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
86 KB (7,929 words) - 11:30, 5 August 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
10 KB (703 words) - 17:18, 20 April 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
6 KB (352 words) - 17:16, 16 May 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
33 KB (3,121 words) - 08:30, 1 July 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
22 KB (2,320 words) - 13:06, 15 August 2024
Troglitazone, bromfenac, trovafloxacin, ebrotidine, nimesulide, nefazodone, ximelagatran and pemoline. Hepatoprotection Reye's syndrome Friedman SE, Grendell...
39 KB (4,074 words) - 11:25, 31 July 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
214 KB (17,120 words) - 01:50, 16 July 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
53 KB (4,941 words) - 09:29, 23 July 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
8 KB (511 words) - 04:42, 7 March 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
27 KB (2,911 words) - 11:28, 24 July 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
26 KB (2,401 words) - 06:25, 16 August 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
10 KB (799 words) - 21:26, 8 June 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
27 KB (2,332 words) - 04:27, 27 February 2024
Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired companies Astra AB...
14 KB (1,191 words) - 05:34, 18 July 2024